100% of moneycontrol users recommend buying Piramal Enter.
What's your call on Piramal Enter today?
Read 3 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||4249.10||0.78||4337.00||2965.00||72,484.77|
|Jun' 15||Mar' 15||Dec' 14||Sep' 14|
|No Mutual Funds Holding the share|
Entertainment Network Ind Recommended on Feb 5th 2015
Recommended price 580.00 | Peak from reco 849.00 46.49%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Piramal Enter is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 15,886.16 crore.
The company management includes Ajay G Piramal - Chairman, Swati A Piramal - Vice Chairperson, Nandini Piramal - Executive Director, Vijay Shah - Executive Director, Gautam Banerjee - Director, Amit Chandra - Director, Keki Dadiseth - Director, R A Mashelkar - Director, Goverdhan Mehta - Director, Siddharth Mehta - Director, S Ramadorai - Director, Deepak Satwalekar - Director, N Vaghul - Director.
It is listed on the BSE with a BSE Code of 500302 and the NSE with an NSE Code of PEL.
Its Registered office is at Piramal Tower, Ganpatrao Kadam Marg,,Lower Parel Mumbai,Maharashtra - 400013.
Their Registrars are Link Intime India Pvt. Ltd.